Dublin, Dec. 09, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/29s8b8/bloodless_glucose) has announced the addition of the "Bloodless Glucose Monitors" report to their offering.
Key Questions Answered
- What are the bloodless monitoring technologies and devices that are moving toward commercialization and that are expected to have an impact on the diabetes management market by the end of the decade?
- What are the products currently under development, and what is their current status in terms of market readiness and product validation?
- What are the signification product development and commercialization issues facing the current generation of bloodless glucose monitors?
- Who are the companies behind bloodless glucose monitors, what are their capabilities and risk factors and what are their key supply chain issues?
- What are the commercialization prospects of the bloodless glucose monitors?
- What are the significant market factors that will impact the market for bloodless glucose monitors?
The convergence of small-scale electronics and sophisticated biocompatible product designs is creating the prospect of bloodless glucose monitoring for patients diagnosed with diabetes. Bloodless glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients.
Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. While the potential is substantial, for most participants the road to commercialization will be rocky due to capitalization requirements and the need for investor patience. Successful players will be those that can form partnerships and strategic alliances.
Key Topics Covered:
1. Executive Summary
- Diabetes Management Market Drivers
- Demographics
- Managed Care
- Global Impact
2. Diabetes Management - A View to 2020
- Monitoring Glucose Levels
- Key Factors in Patient Compliance
- Industry Alignment/Competitive Landscape
- Noninvasive Monitor Design Factors
- Measuring Interstitial Fluid
- Calibration & Reliability
- Accuracy & Precision
- Sensitivity
- Measurement Frequency
3. Data Collection & Reporting
- Patient/User Interface
- Enabling & Emerging Technologies
- Sensor Technology
- Signal Processing Electronics
- Pattern Recognition
- Self-Powered Sensors
4. Noninvasive Glucose Monitors -The Near Term
- Monitors based on Spectroscopy
- Fluorescence
- Hydrogel Matrices
- Monitors based on Multimode Sensing
- Ultrasonic/Conductivity/Heat Capacity
- Transdermal Glucose Measurement
- Ocular Glucose measurement
- Biomarker Measurement
- Wireless Wearable Lens
- Breath Analysis
- Saliva Analysis
- Tears Analysis
- Disposable Reagent
- Tissue Photometry
5. Market Factors
- Regulations
- FDA
- EMEA
- Japan
6. Research Programs
- North America
- Europe
- Israel
- Japan
For more information visit http://www.researchandmarkets.com/research/29s8b8/bloodless_glucose
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Glucose Testing, Diabetes Devices


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 



